Edition:
United States

Hologic Inc (HOLX.OQ)

HOLX.OQ on NASDAQ Stock Exchange Global Select Market

40.43USD
15 Jun 2018
Change (% chg)

-- (--)
Prev Close
$40.43
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
776,581
52-wk High
$46.80
52-wk Low
$35.10

Chart for

About

Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women's health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays,... (more)

Overall

Beta: 0.85
Market Cap(Mil.): $11,037.83
Shares Outstanding(Mil.): 273.01
Dividend: --
Yield (%): --

Financials

  HOLX.OQ Industry Sector
P/E (TTM): -- 38.09 34.18
EPS (TTM): -2.87 -- --
ROI: -12.86 8.73 13.17
ROE: -30.09 12.61 15.15

BRIEF-Hologic Receives Health Canada Authorization To Market Sculpsure Laser

* HOLOGIC RECEIVES HEALTH CANADA AUTHORIZATION TO MARKET SCULPSURE® LASER FOR NON-INVASIVE BODY CONTOURING (LIPOLYSIS) OF THE BACK, INNER AND OUTER THIGHS, AND UNDER THE CHIN Source text for Eikon: Further company coverage:

May 03 2018

BRIEF-Hologic Q2 GAAP Loss Per Share $2.46

* HOLOGIC ANNOUNCES FINANCIAL RESULTS FOR SECOND QUARTER OF FISCAL 2018

May 02 2018

BRIEF-FDA Approval Of Thinprep Integrated Imager Expands Automated Imaging For Pap Testing To More Labs

* FDA APPROVAL OF THINPREP® INTEGRATED IMAGER EXPANDS AUTOMATED IMAGING FOR PAP TESTING TO MORE LABS

Apr 25 2018

BRIEF-Enzo Biochem Says Patent Trial And Appeal Board Has Denied A Petition Filed By Hologic For Inter Partes Review

* ENZO BIOCHEM INC - PATENT TRIAL AND APPEAL BOARD HAS DENIED A PETITION FILED BY HOLOGIC FOR INTER PARTES REVIEW Source text for Eikon: Further company coverage:

Apr 24 2018

BRIEF-FDA Approves New Innovations On Hologic's 3Dimensions™ Mammography System

* FDA APPROVES NEW INNOVATIONS ON HOLOGIC'S 3DIMENSIONS™ MAMMOGRAPHY SYSTEM, THE FASTEST, HIGHEST RESOLUTION BREAST TOMOSYNTHESIS SYSTEM EVER(1)

Mar 27 2018

Appeals court hands win to Smith & Nephew in Hologic patent case

A federal appeals court on Wednesday upheld the validity of a surgical tool patent over which medical device maker Smith & Nephew PLC won a $4 million verdict against rival Hologic Inc.

Mar 14 2018

BRIEF-Koninklijke Philips And Hologic Announce Global Partnership Agreement

* PHILIPS AND HOLOGIC ANNOUNCE GLOBAL PARTNERSHIP AGREEMENT TO PROVIDE INTEGRATED IMAGING SOLUTIONS FOR WOMEN'S HEALTH

Mar 02 2018

BRIEF-Hologic Reports Q1 GAAP Earnings Per Share $1.45

* HOLOGIC ANNOUNCES FINANCIAL RESULTS FOR FIRST QUARTER OF FISCAL 2018

Feb 08 2018

BRIEF-Hologic - CEO's 2017 Total Compensation Was $11.2 Million Vs $10.8 Million‍​

* HOLOGIC INC - CEO STEPHEN P. MACMILLAN'S 2017 TOTAL COMPENSATION WAS $11.2 MILLION VERSUS $10.8 MILLION - SEC FILING‍​ Source text: (http://bit.ly/2nhdmKL) Further company coverage:

Jan 26 2018

Earnings vs. Estimates